Substituted coumarins as potent 5-lipoxygenase inhibitors

被引：42

作者：

Grimm, EL ^{[1
]}

Brideau, C ^{[1
]}

Chauret, N ^{[1
]}

Chan, CC ^{[1
]}

Delorme, D ^{[1
]}

Ducharme, Y ^{[1
]}

Ethier, D ^{[1
]}

Falgueyret, JP ^{[1
]}

Friesen, RW ^{[1
]}

Guay, J ^{[1
]}

Hamel, P ^{[1
]}

Riendeau, D ^{[1
]}

Soucy-Breau, C ^{[1
]}

Tagari, P ^{[1
]}

Girard, Y ^{[1
]}

机构：

[1] Merck Frosst Ctr Therapeut Res, Kirkland, PQ H9H 3L1, Canada

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 09期

关键词：

5-lipoxygenase; leukotrienene inhibitor; coumarin; structure-activity relationship;

D O I：

10.1016/j.bmcl.2006.01.085

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Leukotriene biosynthesis inhibitors have potential as therapeutic agents for asthma and inflammatory diseases. A novel series of substituted coumarin derivatives has been synthesized and the structure-activity relationship was evaluated with respect to their ability to inhibit the formation of leukotrienes via the human 5-lipoxygenase enzyme. (C) 2006 Elsevier Ltd. All rights reserved.

引用

页码：2528 / 2531

页数：4

共 50 条

[31] Recent developments in 5-lipoxygenase inhibitors
Julémont, F
Dogné, JM
Laeckmann, D
Pirotte, B
de Leval, X
EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (01) : 1 - 13
[32] A FLAVONOID, NEW POTENT 5-LIPOXYGENASE INHIBITOR
KOHNO, SW
TAIRA, M
OHATA, K
YAMAMOTO, S
YOKOYAMA, C
HORIE, T
ANNALS OF ALLERGY, 1985, 55 (02): : 362 - 362
[33] Therapeutic options for 5-lipoxygenase inhibitors
Werz, Oliver
Steinhilber, Dieter
PHARMACOLOGY & THERAPEUTICS, 2006, 112 (03) : 701 - 718
[34] DIPYRIDAMOLE - A POTENT AND SPECIFIC 5-LIPOXYGENASE INHIBITOR
CARTER, GW
DYER, R
YOUNG, P
FEDERATION PROCEEDINGS, 1985, 44 (04) : 904 - 904
[35] 5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity
Fischer, A. S.
Metzner, J.
Steinbrink, S. D.
Ulrich, S.
Angioni, C.
Geisslinger, G.
Steinhilber, D.
Maier, T. J.
BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (04) : 936 - 949
[36] CONVERSION OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS INTO EITHER DUAL INHIBITORS OF 5-LIPOXYGENASE AND CYCLOOXYGENASE OR INTO SELECTIVE INHIBITORS OF 5-LIPOXYGENASE
BOSCHELLI, DH
CONNOR, DT
BORNEMEIER, DA
DYER, RD
KUIPERS, PJ
WRIGHT, CD
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 123 - MEDI
[37] STUDIES ON THE SYNTHESIS OF 5-LIPOXYGENASE INHIBITORS
SHIRAISHI, M
KATO, K
OHKAWA, S
TERAO, S
JOURNAL OF PHARMACOBIO-DYNAMICS, 1984, 7 (05): : S95 - S95
[38] HYDROXAMIC ACID INHIBITORS OF 5-LIPOXYGENASE
SUMMERS, JB
MAZDIYASNI, H
HOLMS, JH
RATAJCZYK, JD
DYER, RD
CARTER, GW
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (03) : 574 - 580
[39] Inhibitors of the 5-Lipoxygenase Pathway in Atherosclerosis
Back, Magnus
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (27) : 3116 - 3132
[40] 5-LIPOXYGENASE AND LIPID-PEROXIDATION INHIBITORS - INVITRO ACTIVITY OF SUBSTITUTED PHENOXAZINES
YU, MJ
MCCOWAN, JR
BERTSCH, B
HO, PPK
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 199 : 75 - MEDI

← 1 2 3 4 5 →